Global $4.47 Billion Fill Finish Manufacturing Market 2018-2023 by Product and End-User

Global $4.47 Billion Fill Finish Manufacturing Market 2018-2023 by Product and End-User

DUBLIN, April 10, 2018 /PRNewswire/ --

The "Fill Finish Manufacturing Market by Product (Consumables (Vial, Prefilled Syringes, Cartridge, Single Use Systems), Instruments), End User (Contract Manufacturing Organization, Biopharmaceutical Company, CROs) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The global fill-finish manufacturing market is projected to reach USD 4.47 Billion by 2022 from USD 2.96 Billion in 2017, at a CAGR of 8.6% during the forecast period.

Technological advancements in fill-finish products, growth of the biopharmaceutical industry, rising adoption of prefilled syringes, and increase in fill-finish outsourcing are the major factors driving this market.

By products, the fill-finish manufacturing market is segmented into consumables and instruments. Based on the type of consumables used for filling biologics, the consumables segment is categorized into prefilled syringes, vials, cartridges, and other consumables (ampoules, bottles, bags, and single-use systems). In 2017, the prefilled syringes segment is expected to account for the largest share of the fill-finish manufacturing consumables market. This share of the prefilled syringes market is mainly due to their advantages, such as ease of administration, time and accuracy benefits, safety, and biologic sterility.

By end user, the market is classified into contract manufacturing organizations, biopharma companies, and other end users. In terms of value, the contract manufacturing organizations segment is expected to account for the largest share of the market in 2017. This can primarily be attributed to the rising demand for outsourcing the fill-finish manufacturing process and growing number of new entrants in the biologics manufacturing market.

Geographically, Europe is expected to account for the largest share of the global fill-finish manufacturing market in 2017. The growing focus on the development of biosimilar due to the patent expiry of key biologic products is one of the major factors supporting the growth of the European market. Followed by Europe, North America is expected to account for the second-largest share of the global fill-finish manufacturing market in 2017.

The key players in the fill-finish manufacturing market are Becton, Dickinson and Company (US), West Pharmaceutical Services, Inc. (West Pharmaceutical Services) (US), Gerresheimer AG (Gerresheimer) (Germany), Robert Bosch GmbH (Robert Bosch) (Germany), IMA (Italy), OPTIMA (Germany), and Nipro Medical Corporation (US).

Key Topics Covered

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Primary Data
2.1.1.1 Key Data from Primary Sources
2.1.1.2 Key Industry Insights
2.1.2 Secondary Data
2.1.2.1 Key Data from Secondary Sources
2.2 Market Size Estimation
2.3 Data Triangulation Methodology
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Fill-Finish Manufacturing: Market Overview
4.2 Europe: Fill-Finish Manufacturing Market, 2017
4.3 Fill-Finish Manufacturing Market, By Product, 2017 Vs. 2022
4.4 Fill-Finish Manufacturing Market, By End User

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Driver
5.2.1.1 Technological Advancement in Fill-Finish Products
5.2.1.2 Growth of the Biopharmaceutical Industry
5.2.1.3 Rising Adoption of Prefilled Syringes
5.2.1.4 Rise in Fill-Finish Outsourcing
5.2.2 Restraint
5.2.2.1 High Costs Associated With Isolators/Rabs
5.2.3 Opportunity
5.2.3.1 Growth of Biomanufacturing in Emerging Markets
5.2.4 Challenge
5.2.4.1 Challenges Associated With Manufacturing Prefilled Syringes

6 Fill-Finish Manufacturing Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Prefilled Syringes
6.2.1.1 Glass Prefilled Syringes
6.2.1.2 Plastic Prefilled Syringes
6.2.2 Vials
6.2.3 Cartridges
6.2.4 Other Consumables
6.3 Instruments

7 Fill-Finish Manufacturing Market, By End User
7.1 Introduction
7.2 Contract Manufacturing Organizations
7.3 Biopharmaceutical Companies
7.4 Other End Users

8 Fill-Finish Manufacturing Market, By Region
8.1 Introduction
8.2 Europe
8.2.1 Germany
8.2.2 Uk
8.2.3 France
8.2.4 Rest of Europe
8.3 North America
8.3.1 Us
8.3.2 Canada
8.4 Asia Pacific
8.5 Rest of the World

9 Competitive Landscape
9.1 Market Overview
9.2 Market Ranking Analysis, 2016
9.3 Competitive Situation And Trends
9.3.1 Product Launches & Approvals
9.3.2 Acquisitions
9.3.3 Collaborations, Agreements, And Partnerships
9.3.4 Other Strategies

10 Company Profiles
10.1 Becton, Dickinson and Company (BD)
10.2 West Pharmaceutical Services
10.3 Gerresheimer
10.4 Robert Bosch
10.5 IMA
10.6 Optima
10.7 Bausch + Strbel
10.8 Groninger
10.9 Maquinaria Industrial Dara
10.10 Nipro Medical Corporation
10.11 Schott AG
10.12 SGD
10.13 Stevanato Group

For more information about this report visit https://www.researchandmarkets.com/research/vglrkn/global_4_47?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-4-47-billion-fill-finish-manufacturing-market-2018-2023-by-product-and-end-user-300627219.html

SOURCE Research and Markets